Completed PHASE3 INTERVENTIONAL 2-arm NCT00525707

Tezosentan in Acute Heart Failure (VERITAS 1)

Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.

Sponsor: Idorsia Pharmaceuticals Ltd.

Conditions Acute Decompensation of Chronic Heart Failure Acute Heart Failure New Onset of Heart Failure

Interventions tezosentan

Updated 8 times since 2017 Last updated: Jul 6, 2018 Started: Apr 30, 2003 Primary completion: Jan 31, 2005 Completion: Jan 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00525707, this PHASE3 trial focuses on Acute Decompensation of Chronic Heart Failure and Acute Heart Failure and remains completed. Sponsored by Idorsia Pharmaceuticals Ltd., it has been updated 8 times since 2003, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Aug 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Aug 2018 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Idorsia Pharmaceuticals Ltd.

Data source: Idorsia Pharmaceuticals Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Ashkelon, Israel , Athens, Greece , Bellevue, United States , Berlin, Germany , Birmingham, United States , Boulogne, France , Bydgoszcz, Poland , Danville, United States , Denver, United States and 24 more locations